Ipha

10 results

Minister for Health Simon Harris said pharmaceutical companies might be “reluctant to commit to significant expenditure to address issues that may, or may not, arise”. Photograph: Aidan Crawley

Pharmaceutical companies in Ireland have called on Minister for Health Simon Harris to host a roundtable meeting to ensure the continued supply of med(...)

IPHA president GSK’s Aidan Lynch (centre); IPHA vice-president Paul Reid (Pfizer); and Bayer’s Itziar Canamasas with the Manifesto for Better Health ahead of the IPHA annual conference on November 8th. Photograph: Justin Mac Innes

Big Pharma in Ireland has an image problem. At least that’s how it sees it. “I think we are not seen as a trusted partner,” says Aidan Lynch, presid(...)

The pharmaceutical industry has urged the Government to introduce “predictable multi-annual budgeting” for breakthrough medicines in the budget process.

The pharmaceutical industry is urging the Government to introduce “predictable multiannual budgeting” for breakthrough medicines in the budget process(...)

The Irish Pharmaceutical Healthcare Association says the Government accepts that its medicines bill has been “relatively stable” at about €1.7 billion for the past five years. Photograph: Cyril Byrne

Prices across 750 medicines have fallen in a move that will save the Government €15 million on its drugs budget, according to the industry body Ipha. (...)

Photograph: iStock

Irish patients are being denied access to nine drugs that are widely available across Europe, largely on cost grounds. The drugs – most of them cance(...)

Nine medications are currently stalled at the desk of the Minister for Health even though they have been approved for use by the Health Service Executive

Drug companies are increasingly frustrated at the Government’s failure to offer any assurances on clearing a logjam of new medicines that are waiting (...)

Minister for Health Simon Harris: due to budgetary constraints, many drugs are likely to be frozen out of the Irish market. Photograph: Sam Boal/Rollingnews.ie

The full cost of the Government decision to approve cystic fibrosis drug Orkambi is beginning to be felt by the health service and patients less than (...)

Pfizer’s  Enbrel lost patent protection in Europe earlier this year. Biogen introduced Benepali into the Irish market in September

The price of one of the world’s most popular drugs is falling 30 per cent in Ireland under the terms of a recently signed pricing agreement. Enbrel,(...)

Where a generic medicine is a cheaper identical “copy” of a branded traditional small molecule drug, biosimilar are “me-too” versions of modern, large molecule complex biologic medicines

Switching from a branded biologic drug to a cheaper “biosimilar” makes no meaningful difference to patients suffering from a series of chronic inflamm(...)

The HEA has written to Minister for Health Simon Harris expressing its concern over what it calls the “biosimilar blocker”. Photograph: Dave Meehan

The Health Services Executive could lose out on savings of more than €50 million a year on just three widely used drugs under the terms of the new Med(...)